FAM12 Inhibitors
The chemical class termed Eddm3b Inhibitors encompasses a diverse assortment of compounds that indirectly impinge on the activity or expression of the Eddm3b protein. This class is not defined by a common target or mode of action but instead by the potential to affect Eddm3b through various global cellular mechanisms. These compounds can produce alterations in cellular homeostasis, signaling, gene expression, and protein stability, all of which can, in turn, influence the function or levels of Eddm3b.
Compounds such as chloroquine and bafilomycin A1 can interfere with the cellular degradation pathways, possibly leading to an accumulation of proteins including Eddm3b, while agents like 2-Deoxy-D-glucose and genistein can modulate cellular metabolism and signaling cascades, which may indirectly affect the physiological context in which Eddm3b operates. Inhibitors like Z-VAD-FMK and 17-AAG can protect against apoptosis and protein misfolding, respectively, thus potentially altering the natural lifecycle of Eddm3b within the cell.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
A known autophagy inhibitor, can increase cellular stress, possibly affecting Eddm3b expression or function. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
A glycolysis inhibitor, can alter energy metabolism, potentially influencing Eddm3b activity. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
A vacuolar H+-ATPase inhibitor, can disrupt lysosomal acidification, potentially affecting Eddm3b processing or turnover. | ||||||
Z-VAD-FMK | 187389-52-2 | sc-3067 | 500 µg | $75.00 | 256 | |
A pan-caspase inhibitor, can prevent apoptosis, possibly influencing Eddm3b levels during cellular stress. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
A CaMKII inhibitor, can affect calcium signaling, potentially impacting Eddm3b-related pathways. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
An MEK1/2 inhibitor, can alter the MAPK/ERK pathway, potentially affecting Eddm3b-related signaling. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
A tyrosine kinase inhibitor, can modulate various signaling pathways, potentially impacting Eddm3b. | ||||||
17-AAG | 75747-14-7 | sc-200641 sc-200641A | 1 mg 5 mg | $67.00 $156.00 | 16 | |
An Hsp90 inhibitor, can affect protein folding and stability, potentially influencing Eddm3b expression. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
An Src-family kinase inhibitor, can alter signal transduction, potentially affecting Eddm3b-related functions. | ||||||
Ivermectin | 70288-86-7 | sc-203609 sc-203609A | 100 mg 1 g | $57.00 $77.00 | 2 | |
An inhibitor of certain ion channels, can disrupt neural signaling, potentially impacting Eddm3b in the epididymis. | ||||||